[ Price : $8.95]
A new National Academies report calls on FDA and other federal government entities to take steps to increase the participation of ...[ Price : $8.95]
In the latest move by FDA in its ongoing investigation into the quality of syringes made in China, the agency issues an import ale...[ Price : $8.95]
Two stakeholders comment positively on an FDA public meeting on advancing the use of complex innovative designs in clinical trials...[ Price : $8.95]
FDA warns Mumbai, India-based Kilitch Healthcare India about CGMP violations in its production of sterile ophthalmic drug products...[ Price : $8.95]
FDA warns Jiangsu, China-based Jiangsu Meifan Biotechnology Co. about CGMP violations in the production of finished OTC drugs foun...[ Price : $8.95]
FDA grants Phanes Therapeutics a fast track designation for PT217 and its use in treating patients with extensive-stage small cell...[ Price : $8.95]
Harvard Medical School researchers say fewer than half of the cancer drugs given accelerated approval between 2013 and 2023 demons...[ Price : $8.95]
Federal Register notice: FDA makes available its annual compilation of update notices to the agencys Susceptibility Test Interpret...